XVIVO: High organic growth and distinct economies of scale - Redeye
Q4 is another solid quarter with 44% organic growth (CER), 6-7% above expectations. The main growth driver is disposables, where Thoracic, XVIVO’s largest business unit, delivered 50% organic growth and improved gross margins to 87%.
ANNONS
Q4 is another solid quarter with 44% organic growth (CER), 6-7% above expectations. The main growth driver is disposables, where Thoracic, XVIVO’s largest business unit, delivered 50% organic growth and improved gross margins to 87%.